FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:256-257 January 22, 1998 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Schmidt, P. J. PubMed Citation

During the past decade premenstrual syndrome has become a well-defined entity.¹ The hallmark of the syndrome is the repeated occurrence of behavioral and somatic symptoms severe enough to impair a woman's social and work-related functioning during the luteal phase of the menstrual cycle. On the basis of strict diagnostic criteria, the prevalence of the disorder is estimated to be 2.5 percent among women of reproductive age. No marked racial or ethnic differences in the prevalence of the disorder have been identified.

There are several effective treatments for premenstrual syndrome that have largely supplanted older, unproved therapies such as dietary restrictions, . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.